Nanjing Well Pharmaceutical Group Co.,Ltd. (603351.SS)

CNY 23.8

(0.68%)

Revenue Summary of Nanjing Well Pharmaceutical Group Co.,Ltd.

  • Nanjing Well Pharmaceutical Group Co.,Ltd.'s latest annual revenue in 2023 was 1.15 Billion CNY , up 4.03% from previous year.
  • Nanjing Well Pharmaceutical Group Co.,Ltd.'s latest quarterly revenue in 2024 Q2 was 356.15 Million CNY , up 7.98% from previous quarter.
  • Nanjing Well Pharmaceutical Group Co.,Ltd. reported a annual revenue of 1.11 Billion CNY in annual revenue 2022, up 6.59% from previous year.
  • Nanjing Well Pharmaceutical Group Co.,Ltd. reported a annual revenue of 1.04 Billion CNY in annual revenue 2021, up 41.61% from previous year.
  • Nanjing Well Pharmaceutical Group Co.,Ltd. reported a quarterly revenue of 312.2 Million CNY for 2024 Q3, down -12.34% from previous quarter.
  • Nanjing Well Pharmaceutical Group Co.,Ltd. reported a quarterly revenue of 329.83 Million CNY for 2024 Q1, up 0.82% from previous quarter.

Annual Revenue Chart of Nanjing Well Pharmaceutical Group Co.,Ltd. (2023 - 2014)

Historical Annual Revenue of Nanjing Well Pharmaceutical Group Co.,Ltd. (2023 - 2014)

Year Revenue Revenue Growth
2023 1.15 Billion CNY 4.03%
2022 1.11 Billion CNY 6.59%
2021 1.04 Billion CNY 41.61%
2020 736.06 Million CNY -16.43%
2019 880.75 Million CNY 9.9%
2018 801.45 Million CNY 15.46%
2017 694.11 Million CNY 24.29%
2016 558.44 Million CNY 11.98%
2015 498.69 Million CNY -5.48%
2014 527.59 Million CNY 0.0%

Peer Revenue Comparison of Nanjing Well Pharmaceutical Group Co.,Ltd.

Name Revenue Revenue Difference
Hubei Jumpcan Pharmaceutical Co., Ltd. 9.65 Billion CNY 88.028%
Yabao Pharmaceutical Group Co., Ltd 2.9 Billion CNY 60.277%
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 75.51 Billion CNY 98.469%
Harbin Pharmaceutical Group Co., Ltd. 15.33 Billion CNY 92.464%
Tasly Pharmaceutical Group Co., Ltd 8.54 Billion CNY 86.474%
Zhejiang Medicine Co., Ltd. 7.79 Billion CNY 85.17%
Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited 8.22 Billion CNY 85.943%
Lionco Pharmaceutical Group Co.,Ltd. 196.83 Million CNY -487.223%
Humanwell Healthcare (Group) Co.,Ltd. 24.33 Billion CNY 95.25%
Ginwa Enterprise (Group) Inc. 565.4 Million CNY -104.427%
Joincare Pharmaceutical Group Industry Co.,Ltd. 16.64 Billion CNY 93.056%
Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. 644.97 Million CNY -79.208%
China Animal Husbandry Industry Co., Ltd. 5.4 Billion CNY 78.621%
Jiangsu Jibeier Pharmaceutical Co., Ltd. 860.93 Million CNY -34.254%
Zhejiang Huahai Pharmaceutical Co., Ltd. 8.21 Billion CNY 85.925%
Shanghai Haoyuan Chemexpress Co., Ltd. 1.87 Billion CNY 38.268%
Ningbo Menovo Pharmaceutical Co., Ltd. 1.21 Billion CNY 4.986%
Zhejiang Jiuzhou Pharmaceutical Co., Ltd 5.52 Billion CNY 79.074%
Chongqing Taiji Industry(Group) Co.,Ltd 15.43 Billion CNY 92.511%
HPGC Renmintongtai Pharmaceutical Corporation 10.38 Billion CNY 88.875%
Tianjin Tianyao Pharmaceuticals Co., Ltd. 3.73 Billion CNY 69.048%
Henan Lingrui Pharmaceutical Co., Ltd. 3.31 Billion CNY 65.096%
Shenzhen Chipscreen Biosciences Co., Ltd. 515.78 Million CNY -124.093%
Guizhou Yibai Pharmaceutical Co., Ltd. 2.77 Billion CNY 58.392%
Jiangsu Kanion Pharmaceutical Co.,Ltd. 4.86 Billion CNY 76.255%
Zhongzhu Healthcare Holding Co.,Ltd 580.05 Million CNY -99.263%
Beijing Tongrentang Co., Ltd 17.86 Billion CNY 93.529%
KPC Pharmaceuticals, Inc. 7.62 Billion CNY 84.848%
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co.,Ltd. 845.34 Million CNY -36.73%
North China Pharmaceutical Company Ltd. 10.12 Billion CNY 88.579%
China Resources Double-Crane Pharmaceutical Co.,Ltd. 10.22 Billion CNY 88.693%
Tibet Weixinkang Medicine Co., Ltd. 1.32 Billion CNY 12.612%
China National Medicines Corporation Ltd. 49.69 Billion CNY 97.674%
Zhejiang Hisun Pharmaceutical Co., Ltd. 10.37 Billion CNY 88.857%
Heilongjiang ZBD Pharmaceutical Co., Ltd. 3.13 Billion CNY 63.169%
ChengDu ShengNuo Biotec Co.,Ltd. 430.98 Million CNY -168.184%
Dali Pharmaceuticalco.,Ltd 87.26 Million CNY -1224.442%
Changchun BCHT Biotechnology Co. 1.81 Billion CNY 36.199%
Zhejiang Shengda Bio-Pharm Co., Ltd. 727.4 Million CNY -58.899%
Shanghai Jiaoda Onlly Co.,Ltd 291.91 Million CNY -295.945%
Jiang Zhong Pharmaceutical Co.,Ltd 4.32 Billion CNY 73.291%
Mayinglong Pharmaceutical Group Co., LTD. 3.13 Billion CNY 63.152%
Cisen Pharmaceutical Co., Ltd. 4.46 Billion CNY 74.098%
Hunan Warrant Pharmaceutical Co.,Ltd 1.43 Billion CNY 19.329%
Shanghai Fosun Pharmaceutical (Group) Co., Ltd. 41.39 Billion CNY 97.208%
Jianmin Pharmaceutical Group Co.,Ltd. 4.18 Billion CNY 72.376%
Hunan Fangsheng Pharmaceutical Co., Ltd. 1.62 Billion CNY 29.026%
Guangxi Wuzhou Zhongheng Group Co.,Ltd 3.09 Billion CNY 62.673%
Guobang Pharma Ltd. 5.34 Billion CNY 78.393%
Shaanxi Kanghui Pharmaceutical Co., Ltd. 672.96 Million CNY -71.755%
Kangmei Pharmaceutical Co., Ltd. 4.87 Billion CNY 76.286%
Shandong Buchang Pharmaceuticals Co., Ltd. 13.24 Billion CNY 91.273%
Zhejiang Starry Pharmaceutical Co.,Ltd. 2.17 Billion CNY 46.92%
Henan Taloph Pharmaceutical Stock Co.,Ltd 2.06 Billion CNY 44.16%
ZhuZhou QianJin Pharmaceutical Co.,Ltd 3.79 Billion CNY 69.571%
Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd 3.93 Billion CNY 70.6%
Beijing Sun-Novo Pharmaceutical Research Co., Ltd. 932.12 Million CNY -24.001%
Shanghai Shyndec Pharmaceutical Co., Ltd. 11.93 Billion CNY 90.313%
Shanghai Yizhong Pharmaceutical Co., Ltd. 360.25 Million CNY -220.84%
Tibet Rhodiola Pharmaceutical Holding Co. 3.09 Billion CNY 62.669%
Sichuan Huiyu Pharmaceutical Co., Ltd. 920.34 Million CNY -25.587%
Zhejiang Cheng Yi Pharmaceutical Co., Ltd. 671.62 Million CNY -72.096%
CanSino Biologics Inc. 345.18 Million CNY -234.849%
Jiangsu Lianhuan Pharmaceutical Co., Ltd. 2.17 Billion CNY 46.836%
Shandong Lukang Pharmaceutical Co.,Ltd. 6.14 Billion CNY 81.196%